Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/CAAC.21660
Wöll E, Eisterer W, Gerger A et al (2019) Treatment algorithm for patients with gastric adenocarcinoma: an Austrian consensus on systemic therapy. Anticancer Res 39:4589–4596. https://doi.org/10.21873/ANTICANRES.13638
Chrom P, Stec R, Szczylik C (2015) Second-line treatment of advanced gastric cancer: current options and future perspectives. Anticancer Res 35:4575–4583
Mandal A, Thakur R, Kumar C et al (2024) The pattern of recurrence after curative resection of gastric cancer in a tertiary cancer center in North India. Indian J Surg Oncol 1–7. https://doi.org/10.1007/S13193-024-02153-Z/METRICS
Wagner AD, Lordick F, Grabsch HI et al (2020) Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer. Eur J Cancer 124:67–76. https://doi.org/10.1016/J.EJCA.2019.09.006
Degiuli M, De Manzoni G, Di Leo A et al (2016) Gastric cancer: current status of lymph node dissection. World J Gastroenterol 22:2875. https://doi.org/10.3748/WJG.V22.I10.2875
Article CAS PubMed PubMed Central Google Scholar
Chon S-H, Berlth F, Plum PS et al (2017) Gastric cancer treatment in the world: Germany. Transl Gastroenterol Hepatol 2:53. https://doi.org/10.21037/TGH.2017.05.07
Article PubMed PubMed Central Google Scholar
Okajima W, Komatsu S, Ichikawa D et al (2016) Prognostic impact of the number of retrieved lymph nodes in patients with gastric cancer. J Gastroenterol Hepatol 31:1566–1571. https://doi.org/10.1111/jgh.13306
Lee CM, Park SS, Kim JH (2015) Current status and scope of lymph node micrometastasis in gastric cancer. J Gastric Cancer 15:1. https://doi.org/10.5230/JGC.2015.15.1.1
Article PubMed PubMed Central Google Scholar
Hou Y, Wang X, Chen J (2018) Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer. World J Surg Oncol 16:1–9. https://doi.org/10.1186/S12957-018-1504-5/FIGURES/3
Wei F, Lyu H, Wang S et al (2020) Positive lymph node ratio as a novel indicator of prognosis in gastric signet ring cell carcinoma: a population-based retrospective study. Transl Cancer Res 9:3658. https://doi.org/10.21037/TCR.2020.04.04
Article PubMed PubMed Central Google Scholar
Komatsu S, Ichikawa D, Miyamae M et al (2016) Positive lymph node ratio as an indicator of prognosis and local tumor clearance in N3 gastric cancer. J Gastrointest Surg 209(20):1565–1571. https://doi.org/10.1007/S11605-016-3197-9
Siewert JR, Böttcher K, Stein HJ et al (1998) Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 1998 228 4:449–61. https://doi.org/10.1097/00000658-199810000-00002
Nitti D, Marchet A, Olivieri M et al (2003) Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol 10:1077–1085. https://doi.org/10.1245/ASO.2003.03.520
Fukuda N, Sugiyama Y, Midorikawa A, Mushiake H (2009) Prognostic significance of the metastatic lymph node ratio in gastric cancer patients. World J Surg 33:2378–2382. https://doi.org/10.1007/S00268-009-0205-1
Aoyama T, Komori K, Tamagawa A et al (2022) Clinical influence of the lymph node ratio on lymph node metastasis-positive gastric cancer patients who receive curative treatment. In Vivo (Brooklyn) 36:994–1000. https://doi.org/10.21873/INVIVO.12792
Giuffrida M, Viani L, Giovanni Iapichino G et al (2021) The metastatic lymph node ratio is a better prognostic factor than the number of metastatic limph node after curative resection for gastric cancer. Acta Biomed 92:2021284. https://doi.org/10.23750/abm.v92i5.9682
Wang H, Xing XM, Ma LN et al (2018) Metastatic lymph node ratio and lauren classification are independent prognostic markers for survival rates of patients with gastric cancer. Oncol Lett 15:8853–8862. https://doi.org/10.3892/OL.2018.8497/HTML
Article PubMed PubMed Central Google Scholar
Zhu J, Xue Z, Zhang S et al (2018) Integrated analysis of the prognostic role of the lymph node ratio in node-positive gastric cancer: a meta-analysis. Int J Surg 57:76–83. https://doi.org/10.1016/J.IJSU.2018.08.002
Calero A, Escrig-Sos J, Mingol F et al (2015) Usefulness of the log odds of positive lymph nodes to predict and discriminate prognosis in gastric carcinomas. J Gastrointest Surg 19:813–820. https://doi.org/10.1007/S11605-014-2728-5
Article CAS PubMed Google Scholar
Jian-hui C, Shi-rong C, Hui W et al (2016) Prognostic value of three different lymph node staging systems in the survival of patients with gastric cancer following D2 lymphadenectomy. Tumour Biol 37:11105–11113. https://doi.org/10.1007/S13277-015-4191-7
Sun Z, Xu Y, Li DM et al (2010) Log odds of positive lymph nodes: a novel prognostic indicator superior to the number-based and the ratio-based N category for gastric cancer patients with R0 resection. Cancer 116:2571–2580. https://doi.org/10.1002/CNCR.24989
Wang J, Hassett JM, Dayton MT, Kulaylat MN (2008) The prognostic superiority of log odds of positive lymph nodes in stage III colon cancer. J Gastrointest Surg 12:1790–1796. https://doi.org/10.1007/S11605-008-0651-3
Gu P, Deng J, Sun Z et al (2021) Superiority of log odds of positive lymph nodes (LODDS) for prognostic prediction after gastric cancer surgery: a multi-institutional analysis of 7620 patients in China. Surg Today 51:101–110. https://doi.org/10.1007/S00595-020-02091-7
Mohri Y, Tanaka K, Ohi M et al (2010) Prognostic significance of host- and tumor-related factors in patients with gastric cancer. World J Surg 34:285–290. https://doi.org/10.1007/s00268-009-0302-1
Park J-M, Ryu W-S, Kim J-H et al (2006) Prognostic factors for advanced gastric cancer: stage-stratified analysis of patients who underwent curative resection. Cancer Res Treat 38:13. https://doi.org/10.4143/crt.2006.38.1.13
Article PubMed PubMed Central Google Scholar
JGCA (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14:101–112. https://doi.org/10.1007/s10120-011-0041-5
Sobin LH, Compton CC (2010) TNM seventh edition: what’s new, what’s changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer. Cancer 116:5336–5339. https://doi.org/10.1002/cncr.25537
Brierley J, Gospodarowicz MD, Wittekind CT (2017) TNM classification of malignant tumors international union against cancer. In: 8th. Oxford, England: Wiley; 2017. Oesphagus including oesophagogastric junction. Wiley pp 57–62
Chen YH, Lu J, Nie RC et al (2021) Retrieval of 30 lymph nodes is mandatory for selected stage II gastric cancer patients. Front Oncol 11:593470. https://doi.org/10.3389/FONC.2021.593470
Article PubMed PubMed Central Google Scholar
Pedrazzani C, Sivins A, Ancans G et al (2009) Ratio between metastatic and examined lymph nodes (N ratio) may have low clinical utility in gastric cancer patients treated by limited lymphadenectomy: results from a single-center experience of 526 patients. World J Surg 341(34):85–91. https://doi.org/10.1007/S00268-009-0288-8
Siewert JR, Kestlmeier R, Busch R et al (1996) Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg 83:1144–1147. https://doi.org/10.1002/BJS.1800830836
Article CAS PubMed Google Scholar
Sianesi M, Bezer L, Del Rio P et al (2010) The node ratio as prognostic factor after curative resection for gastric cancer. J Gastrointest Surg 14:614–619. https://doi.org/10.1007/S11605-009-1142-X
Persiani R, Rausei S, Antonacci V et al (2009) Metastatic lymph node ratio: a new staging system for gastric cancer. World J Surg 33:2106–2111. https://doi.org/10.1007/S00268-009-0157-5
Comments (0)